Prevention of coronary heart disease in clinical practice:: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

被引：380

作者：

Wood, D ^{[1
]}

De Backer, G ^{[1
]}

Faergeman, O ^{[1
]}

Graham, I ^{[1
]}

Mancia, G ^{[1
]}

Pyörälä, K ^{[1
]}

机构：

[1] Univ London Imperial Coll Sci Technol & Med, Sch Med, Natl Heart & Lung Inst, London SW3 6LY, England

来源：

ATHEROSCLEROSIS | 1998年 / 140卷 / 02期

关键词：

D O I：

10.1016/S0021-9150(98)90209-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：199 / 270

页数：72

共 472 条

[1] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL, TOTAL CHOLESTEROL SCREENING, AND MYOCARDIAL-INFARCTION - THE FRAMINGHAM-STUDY [J].

ABBOTT, RD ;

WILSON, PWF ;

KANNEL, WB ;

CASTELLI, WP .

ARTERIOSCLEROSIS, 1988, 8 (03) :207-211

[2] CAROTID INTIMA-MEDIA THICKNESS IS ONLY WEAKLY CORRELATED WITH THE EXTENT AND SEVERITY OF CORONARY-ARTERY DISEASE [J].

ADAMS, MR ;

NAKAGOMI, A ;

KEECH, A ;

ROBINSON, J ;

MCCREDIE, R ;

BAILEY, BP ;

BENFREEDMAN, S ;

CELERMAJER, DS .

CIRCULATION, 1995, 92 (08) :2127-2134

[3] Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men - A general population study [J].

Adlerberth, AM ;

Rosengren, A ;

Wilhelmsen, L .

DIABETES CARE, 1998, 21 (04) :539-545

[4]

Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO

[5]

2-S

[6] RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY [J].

ALFTHAN, G ;

PEKKANEN, J ;

JAUHIAINEN, M ;

PITKANIEMI, J ;

KARVONEN, M ;

TUOMILEHTO, J ;

SALONEN, JT ;

EHNHOLM, C .

ATHEROSCLEROSIS, 1994, 106 (01) :9-19

[7]

Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501

[8] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[9]

*AM ASS CARD PULM, 1995, GUID CARD REH

[10]

Amant C, 1997, CIRCULATION, V96, P56

← 1 2 3 4 5 6 7 8 9 10 →